Gordon Carl L

Director, 10% OwnerTheseus Pharmaceuticals, Inc. (THRX) · full profile →Form 4 · filed Jan 13, 2022
Net Buying
Open-Market Buys
$443K
Open-Market Sells
$0
Net Open-Market Flow
$443K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 13, 2022Buy(P)17K$9.43$163K16.4M
Jan 12, 2022Buy(P)19K$10.06$190K16.4M
Jan 11, 2022Buy(P)2K$9.81$16K16.3M
Jan 11, 2022Buy(P)7K$10.67$74K16.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-22-000050) within minutes of acceptance. Every field above traces to the original document. Verify it directly: